Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effect of Sacral Erector Spinae Plane Block on Quality of Recovery After Cesarean Delivery: A Prospective Randomized Controlled Trial

NCT07900997 is registered in ClinicalTrials.gov with Konya City Hospital as lead sponsor.

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, 14-day trial. Card required. Your first charge is when the trial ends. See pricing

Get the NCT07900997 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Follow this trial by email

Registry record

As filed in ClinicalTrials.gov.

Title
Effect of Sacral Erector Spinae Plane Block on Quality of Recovery After Cesarean Delivery: A Prospective Randomized Controlled Trial
Lead sponsor
Konya City Hospital
Phase
Not applicable
Overall status
Not yet recruiting
Start date
November 1, 2026
Completion date
May 1, 2027
Enrollment
80 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

Arms

As registered; 2 arms.

  • sacral erector spinae plane block Active comparatorPostoperative Analgesia Protocol

    The ESP block will be performed bilaterally, with 20 mL of local anesthetic solution injected on each side between the multifidus muscle and the median sacral crest. For each side, the solution will be prepared by diluting 10 mL of 0.5% bupivacaine with 10 mL of 0.9% sodium chloride, yielding a final bupivacaine concentration of 0.25% (50 mg per side; 100 mg in total).

  • Multiple modal analgesia Sham comparatorPostoperative Analgesia Protocol

    After surgery under spinal anesthesia has been completed, patients will undergo the sham block procedure in the PACU. They will also receive intravenous paracetamol, 1 g three times daily, and 50 mg dexketoprofen as rescue analgesia when the NRS score is ≥3.

Primary endpoints

Registered primary outcome measures; 1 primary.

  • quality of recovery-10 one day

    The primary outcome will be assessed using the Obstetric Quality of Recovery-10-Turkish (ObsQoR-10T) scale, whose Turkish validity and reliability were established by Kozanhan et al. The scale assesses 10 domains: pain, nausea and vomiting, dizziness, shivering, comfort, independent mobilization, personal hygiene, feeding/breastfeeding the baby without assistance, holding the baby without assistance, and a sense of control. Each item is scored from 0 to 10. The first four items, which assess adverse symptoms, are reverse-scored before calculating the total score. The total score ranges from 0 to 100, with higher scores indicating better postpartum quality of recovery. The scale will be administered at 24 hours postoperatively.

Lead sponsor's other trials

Konya City Hospital, most recent start first.

Similar trials

Same condition (Postoperative Pain) and phase, most recent start first.